An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer

Pancreatic ductal adenocarcinoma rapidly acquires resistance to chemotherapy, remaining a fatal disease. Immunotherapy is one of the breakthroughs in cancer treatment, which includes immune checkpoint inhibitors, chimeric antigen receptor T‐cell immunotherapy, and neoantigen vaccines. However, immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Junming, Wang, Meng, Zhang, Fu, Shao, Shiyi, Yao, Zhuo, Zhao, Xinyu, Hu, Qida, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074093/
https://www.ncbi.nlm.nih.gov/pubmed/36698308
http://dx.doi.org/10.1002/advs.202206756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074093/
https://www.ncbi.nlm.nih.gov/pubmed/36698308
http://dx.doi.org/10.1002/advs.202206756

Ejemplares similares